Lung Cancer, COPD & Pneumonia: The triple threat of Smoking

Time and again the message of caution that smoking is injurious to health has been propagated over various mediums of […]

Increased dust, air pollution increasing COPD cases post lockdown

Amid fear and uncertainties, Covid 19 pandemic has given us a less polluted environment. The lockdown imposed throughout the country […]

Diagnose COPD early to prevent lung & heart attack

According to reports, Chronic Obstructive Pulmonary Disease (COPD) is causing 2300 deaths per day in India; India has become the […]

Novartis Healthcare Launches Sequadra Inhaler for Advance Treatment of COPD Patients

Novartis Healthcare Private Limited (NHPL) launched Sequadra Inhaler (indacaterol/glycopyrronium) 110mcg/50mcg, a fixed dose combination (FDC) of two bronchodilating active ingredients, […]

i2india expands reach with LungFlute in India

i2india Ventures, a technology major, is expanding the availability of its lung-care device known as the LungFlute. The innovative medical […]

Lung cancer can have an early detection now

Scientists have developed a method to detect early signs of lung cancer by examining cheek cells in humans using pioneering biophotonics technology, reports the journal Cancer Research in its online edition.

New MRI machine eliminates claustrophobia

Loyola University Health System now offers a powerful new MRI machine that can scan a leg or an arm without many of the usual inconveniences.

InferMed partners with NHS Cambridgeshire to improve patient care

InferMed is pleased to announce its partnership with NHS Cambridgeshire in a pilot project that will uate the use of best practice guidelines for COPD (Chronic Obstructive Pulmonary Disease).

Research News: May 2011

More kids exposed to ionizing radiation with CT scan CT scans are being used on more and more children in […]

Asthma and COPD Inhalers containing Ozone-depleting CFCs to be Phased Out

The US Food and Drug Administration has announced, in accordance with longstanding US obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the US marketplace.

GE Healthcare and Intel Expand Intel Health Guide Marketing Agreement

GE Healthcare and Intel Corporation have expanded their sales and marketing agreement for the Intel Health Guide to include the United Kingdom.

Intel’s personal health management system

A home medical device, designed to be part of a remote personal home care management system for people with chronic conditions, has been launched by Intel.

NEWS REVIEW – WORLD

[This article was published in the March 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

News Review